DrugInfoSys

Fluticasone Propionate

Drug #1456

Fluticasone Propionate is a synthetic corticosteroid with mainly glucocorticocoid activity. Fluticasone Propionate is used by oral inhalation for the prophylactic treatment of asthma. Fluticasone Propionate is reported to have a local effect on lungs without causing significant systemic effects, reduces airway inflammation and hence reduces oedema and secretions of mucous into the airway. It also is used as a nasal spray in the treatment of allergic rhinitis. When applied topically used in the treatment of various skin disorders. Fluticasone approved by FDA in december 1990

Primary Characteristics

It is of Synthetic origin and belongs to Corticosteroid.

Molecular Weight: 500.6 · pKa: not ionizable · Solubility in Water: Insoluble · Non-proprietary name: Fluticasone Propionate.

Molecular structure of Fluticasone Propionate

Pharmacokinetics

Absorption: Fluticasone Propionate has an oral bioavailability is 10% (±10%), pre-systemic (first-pass) metabolism accounts for 50% (±50%).

Distribution: Fluticasone Propionate has a volume of distribution is 258 litre. plasma protein binding is 81-95%.

Elimination: plasma half-life is 3.1hr, renal excretion is < 5%.

Advertisement

Indications

Contraindications

Dosage

Fluticasone Propionate's dosage details are as follows:

DoseSingle DoseFrequencyRouteInstructions
Adult Dosage
0.05 %0.05 %Every 24hTopicalFrequency may be increased upto twice daily if needed.
Paediatric Dosage (20kg)
No data.
Neonatal Dosage (3kg)
No data.

Drug Interactions

Unknown8 interactions
1 interaction

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

Fluticasone Propionate in overdosage may give rise to further complications which include Glaucoma , Adrenocortical suppression, Growth retardation , Cataract, Decrease in bone mineral density.

Fluticasone Propionate is known to cause more or less tolerable side effects which are usually transient. These include Allergic contact dermatitis , Cough , Dysphonia, Hypercortisolism, Hyperpigmentation , Hypertrichosis , Local burning, Oral candidiasis, Pruritus , Secondary dermatitis, Superficial blood vessels dilatation, Superficial blood vessels thinning, Throat irritation, Vocal cord myopathy.

Warnings / Precautions

It should be used with caution in patients with active tuberculosis infection of respiratory tract or in untreated fungal, bacterial or systemic viral infections. Corticosteroids should only be used systemically with great caution in the presence of congestive heart failure (CHF), recent myocardial infraction (MI), hypertension, diabetes mellitus, epilepsy, glaucoma, hypothyroidism, liver failure, osteoporosis, peptic ulceration or renal impairment. Children may be at increase risk of some adverse effects, corticosteroid causes growth retardation and prolonged use is rarely justified. Live vaccine should not be given to patients receiving high dose systemic corticosteroid therapy nor for atleast 3 months afterwards, killed vaccine or toxoids may be given, although the response may be attenuated. During prolong treatment with corticosteroids, patients should be examined regularly, sodium intake may need to be reduced and calcium and potassium supplement may be necessary. Patient should carry cards given full details of their corticosteroid therapy. Avoid use during pregnancy. Use nasal steroids with caution until healing has occurred. Care should be taken when using corticosteroid topically to ensure the amount applied is the inimum that provides therapeutic benefit. When applied to eyelids, care is needed to ensure that the preparation does not enter the eye so as to avoid the risk of local irritation or gluacoma. Appropriate antimicrobial therapy should be used whenever treating inflammatory lesions which have become infected. Any spread of infection requires withdrawal of topical corticosteroid therapy and systemic administration of antimicrobial agents.

Available Brands

Click on a strength to view available brands.

Multi-Ingredient Combinations

Storage Conditions

Fluticasone Propionate should be stored Inhaler, Nasal Spray, Cream, Oint..

Drug Classification

  1. 1.13.3.1Corticosteroids plain
  2. 2.13.9Anti-psoriatics
  3. 3.25.1.2Inhalants
  4. 4.25.4Nasal preparations

Manufacturers

Manufacturers of Fluticasone Propionate in Pakistan: